Cargando…

A genetic variant in miR‐100 is a protective factor of childhood acute lymphoblastic leukemia

BACKGROUND: In the past decade, miR‐100, miR‐146a, and miR‐210 were reported to be dysregulated in childhood acute lymphoblastic leukemia (ALL). However, effects of genetic variants in these three microRNAs have not been investigated in Chinese population. METHODS: In this study, we conducted a case...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Yao, Yang, Xiaoyun, Hu, Shaoyan, Kang, Meiyun, Chen, Jing, Fang, Yongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536980/
https://www.ncbi.nlm.nih.gov/pubmed/30848099
http://dx.doi.org/10.1002/cam4.2082
_version_ 1783421897827942400
author Xue, Yao
Yang, Xiaoyun
Hu, Shaoyan
Kang, Meiyun
Chen, Jing
Fang, Yongjun
author_facet Xue, Yao
Yang, Xiaoyun
Hu, Shaoyan
Kang, Meiyun
Chen, Jing
Fang, Yongjun
author_sort Xue, Yao
collection PubMed
description BACKGROUND: In the past decade, miR‐100, miR‐146a, and miR‐210 were reported to be dysregulated in childhood acute lymphoblastic leukemia (ALL). However, effects of genetic variants in these three microRNAs have not been investigated in Chinese population. METHODS: In this study, we conducted a case‐control study to evaluate the relationship between genetic variants in miR‐100, miR‐146a, and miR‐210 and the risk of childhood ALL in Chinese population. Subsequently, plasma expression level of miR‐100 was also detected. RESULT: We found that subjects carrying mutant homozygous TT genotype of miR‐100 rs543412 had a statistically significantly decreased risk of childhood ALL (adjusted odds ratio [OR] = 0.73, 95% confidence interval [CI] = 0.55‐0.97, P = 0.029). This protective effect was also observed among subjects whose parents were ever drinkers (adjusted OR = 0.53, 95% CI = 0.29‐0.94), or whose living house were ever painted (adjusted OR = 0.57, 95% CI = 0.34‐0.94). Besides, rs543412 variant homozygous TT had a significantly protective role in patients with childhood B‐ALL. Finally, we found that expression level of miR‐100 in plasma of childhood ALL cases was significantly higher than that of noncancer controls. CONCLUSION: Our study suggested that there was significant association between the polymorphisms in miR‐100 (rs543412) and decreased susceptibility to childhood ALL.
format Online
Article
Text
id pubmed-6536980
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65369802019-06-03 A genetic variant in miR‐100 is a protective factor of childhood acute lymphoblastic leukemia Xue, Yao Yang, Xiaoyun Hu, Shaoyan Kang, Meiyun Chen, Jing Fang, Yongjun Cancer Med Cancer Prevention BACKGROUND: In the past decade, miR‐100, miR‐146a, and miR‐210 were reported to be dysregulated in childhood acute lymphoblastic leukemia (ALL). However, effects of genetic variants in these three microRNAs have not been investigated in Chinese population. METHODS: In this study, we conducted a case‐control study to evaluate the relationship between genetic variants in miR‐100, miR‐146a, and miR‐210 and the risk of childhood ALL in Chinese population. Subsequently, plasma expression level of miR‐100 was also detected. RESULT: We found that subjects carrying mutant homozygous TT genotype of miR‐100 rs543412 had a statistically significantly decreased risk of childhood ALL (adjusted odds ratio [OR] = 0.73, 95% confidence interval [CI] = 0.55‐0.97, P = 0.029). This protective effect was also observed among subjects whose parents were ever drinkers (adjusted OR = 0.53, 95% CI = 0.29‐0.94), or whose living house were ever painted (adjusted OR = 0.57, 95% CI = 0.34‐0.94). Besides, rs543412 variant homozygous TT had a significantly protective role in patients with childhood B‐ALL. Finally, we found that expression level of miR‐100 in plasma of childhood ALL cases was significantly higher than that of noncancer controls. CONCLUSION: Our study suggested that there was significant association between the polymorphisms in miR‐100 (rs543412) and decreased susceptibility to childhood ALL. John Wiley and Sons Inc. 2019-03-07 /pmc/articles/PMC6536980/ /pubmed/30848099 http://dx.doi.org/10.1002/cam4.2082 Text en © 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cancer Prevention
Xue, Yao
Yang, Xiaoyun
Hu, Shaoyan
Kang, Meiyun
Chen, Jing
Fang, Yongjun
A genetic variant in miR‐100 is a protective factor of childhood acute lymphoblastic leukemia
title A genetic variant in miR‐100 is a protective factor of childhood acute lymphoblastic leukemia
title_full A genetic variant in miR‐100 is a protective factor of childhood acute lymphoblastic leukemia
title_fullStr A genetic variant in miR‐100 is a protective factor of childhood acute lymphoblastic leukemia
title_full_unstemmed A genetic variant in miR‐100 is a protective factor of childhood acute lymphoblastic leukemia
title_short A genetic variant in miR‐100 is a protective factor of childhood acute lymphoblastic leukemia
title_sort genetic variant in mir‐100 is a protective factor of childhood acute lymphoblastic leukemia
topic Cancer Prevention
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536980/
https://www.ncbi.nlm.nih.gov/pubmed/30848099
http://dx.doi.org/10.1002/cam4.2082
work_keys_str_mv AT xueyao ageneticvariantinmir100isaprotectivefactorofchildhoodacutelymphoblasticleukemia
AT yangxiaoyun ageneticvariantinmir100isaprotectivefactorofchildhoodacutelymphoblasticleukemia
AT hushaoyan ageneticvariantinmir100isaprotectivefactorofchildhoodacutelymphoblasticleukemia
AT kangmeiyun ageneticvariantinmir100isaprotectivefactorofchildhoodacutelymphoblasticleukemia
AT chenjing ageneticvariantinmir100isaprotectivefactorofchildhoodacutelymphoblasticleukemia
AT fangyongjun ageneticvariantinmir100isaprotectivefactorofchildhoodacutelymphoblasticleukemia
AT xueyao geneticvariantinmir100isaprotectivefactorofchildhoodacutelymphoblasticleukemia
AT yangxiaoyun geneticvariantinmir100isaprotectivefactorofchildhoodacutelymphoblasticleukemia
AT hushaoyan geneticvariantinmir100isaprotectivefactorofchildhoodacutelymphoblasticleukemia
AT kangmeiyun geneticvariantinmir100isaprotectivefactorofchildhoodacutelymphoblasticleukemia
AT chenjing geneticvariantinmir100isaprotectivefactorofchildhoodacutelymphoblasticleukemia
AT fangyongjun geneticvariantinmir100isaprotectivefactorofchildhoodacutelymphoblasticleukemia